CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer
Wang, Yu-xiang2; Li, Xian2; Liu, Xue-ling2; Wang, Bo-bo3; Chen, Yi2; Yang, Chun-hao1; Ding, Jian2; Meng, Ling-hua2
刊名MOLECULAR CANCER RESEARCH
2020-10-01
卷号18期号:10页码:44-45
ISSN号1541-7786
WOS研究方向Oncology ; Cell Biology
语种英语
出版者AMER ASSOC CANCER RESEARCH
WOS记录号WOS:000576804500063
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/290378]  
专题中国科学院上海药物研究所
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, Shanghai, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai, Peoples R China
3.Zhejiang Univ, Sch Pharm, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Wang, Yu-xiang,Li, Xian,Liu, Xue-ling,et al. Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer[J]. MOLECULAR CANCER RESEARCH,2020,18(10):44-45.
APA Wang, Yu-xiang.,Li, Xian.,Liu, Xue-ling.,Wang, Bo-bo.,Chen, Yi.,...&Meng, Ling-hua.(2020).Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer.MOLECULAR CANCER RESEARCH,18(10),44-45.
MLA Wang, Yu-xiang,et al."Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer".MOLECULAR CANCER RESEARCH 18.10(2020):44-45.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace